Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| Consensus cluster analysis of apoptosis-related genes in patients with osteoarthritis and their correlation with immune cell infiltration. | Front Immunol | 2023 | 37860011 | PubTator, text mining | PubMed |
| Toxoplasma gondii infection regulates apoptosis of host cells via miR-185/ARAF axis. | Parasit Vectors | 2023 | 37858158 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function. | Front Cell Dev Biol | 2023 | 37842094 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study. | Cancers (Basel) | 2023 | 37835512 | PubTator, text mining | PubMed |
| The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies. | Int J Mol Sci | 2023 | 37834222 | PubTator, text mining | PubMed |
| Theoretical analysis reveals a role for RAF conformational autoinhibition in paradoxical activation. | Elife | 2023 | 37823369 | PubTator, text mining | PubMed |
| Primary unifocal thymic Rosai-Dorfman disease: an extremely rare challenge in diagnostic practice. | J Cardiothorac Surg | 2023 | 37817188 | PubTator, text mining | PubMed |
| miR-624 accelerates the growth of liver cancer cells by inhibiting EMC3. | Noncoding RNA Res | 2023 | 37810370 | PubTator, text mining | PubMed |
| Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor. | Front Pharmacol | 2023 | 37808191 | PubTator, text mining | PubMed |
| Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. | Mol Cancer | 2023 | 37803407 | PubTator, text mining | PubMed |
| Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review). | Oncol Rep | 2023 | 37800636 | PubTator, text mining | PubMed |
| Proliferation-associated 2G4 P48 is stabilized by malignant T-cell amplified sequence 1 and promotes the proliferation of head and neck squamous cell carcinoma. | J Dent Sci | 2023 | 37799877 | PubTator, text mining | PubMed |
| Recalcitrant primary cutaneous Rosai-Dorfman disease. Efficacy of sirolimus and intralesional methylprednisolone. | Skin Health Dis | 2023 | 37799357 | PubTator, text mining | PubMed |
| Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population. | PLoS One | 2023 | 37796807 | PubTator, text mining | PubMed |
| PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study. | BMC Gastroenterol | 2023 | 37784019 | PubTator, text mining | PubMed |
| Structure characterization of novel heteropolysaccharides from Pteridium revolutum with antioxidant and antiglycated activities. | Food Chem X | 2023 | 37780250 | PubTator, text mining | PubMed |
| The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma. | J Cell Mol Med | 2023 | 37772815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=7